Catheter Related Bloodstream Infection (CRBSI) Market Proposal, Demand And Trade Analysis 2023 to 2033

 The Catheter Related Bloodstream Infection (CRBSI) Market is anticipated to reach US$ 44.67 billion in 2023 and US$ 80 billion by 2023 to 2033 at a CAGR of 6%. The rise in the market for catheter-related bloodstream infections can be linked to the rise in the number of persons who experience urine infections. The market for catheter-related bloodstream infections increased historically at a CAGR of 4.5% from 2017 to 2022.

An increasing number of surgeries due to a rise in the number of chronic ailments such as diabetes, cardiovascular disorders, urological disorders, end-stage renal diseases, and other chronic conditions is expected to increase the adoption rate of catheters. This, in tun, is expected to increase the chances of patients suffering from catheter-related bloodstream infection market.

To learn more about this report: https://www.futuremarketinsights.com/reports/catheter-related-bloodstream-infection-crbsi-market

Furthermore, technological advancements play crucial role in fueling the market growth. For instance, miniaturized catheters and introduction of antimicrobial catheters are expected to reduce catheter-associated infections Although major players are innovating, launching and introducing safer catheters, the limited expansion of the same is contributing to the market for catheter-related bloodstream infusions.

Key Takeaways from the Market Study

  • By distribution channel, hospital pharmacies are expected to possess 40% market share for catheter-related bloodstream infections market in 2023.
  • By drug class, antimicrobial catheters are expected to possess 35% market share for catheter-related bloodstream infections in 2023.
  • North America is expected to possess 35% market share for catheter-related bloodstream infection market in 2023.
  • Asia Pacific is expected to possess 30% market share for catheter-related bloodstream infection market in 2023.

“Rise in prevalence of diseases that require catheter are increasing the number of patients suffering from catheter-related bloodstream infections. This, in turn, is supporting the growth of the market.” states a FMI analyst

Competitive Landscape

Key players in the catheter-related bloodstream infection are Xellia Pharmaceuticals Ltd, Pfizer, Glenmark Pharmaceuticals Ltd, Fresenius Medical Care, CorMedix, TauroPhar GmbH, Geistlich Pharma, Citus Pharmaceuticals, AstraZeneca Pharma India Ltd, Merck Sharp & Dohme Corp

  • In August 2021, Xellia Pharmaceuticals (‘Xellia’), a global leader in the manufacturing of specialty anti-infective treatments, announced that its manufacturing site in Cleveland, Ohio is now commercially operational and has released the first anti-infectives manufactured at the site, to be distributed for use by US hospitals.
  • In February 2020, CorMedix, Inc. announced that Neutrolin received grant from the U.S. Food and Drug Administration for the prevention of catheter-related bloodstream infections (CRBSIs) in hemodialysis patients.

Central line-associated bloodstream infection (CLABSI) is an infection that occurs when bacteria or other microorganisms enter the bloodstream through a catheter. Catheters are medical devices that are inserted into the body to deliver fluids, medications, or nutrition. They are commonly used in hospitals, long-term care facilities, and in the home for patients who require ongoing medical treatment.

Key Companies Profiled: 

  • Xellia Pharmaceuticals Ltd.
  • Pfizer
  • Glenmark Pharmaceuticals Ltd.
  • Fresenius Medical Care
  • CorMedix
  • TauroPhar GmbH
  • Geistlich Pharma
  • Citus Pharmaceuticals
  • AstraZeneca Pharma India Ltd.
  • Merck Sharp & Dohme Corp

Key Segments Profiled in the Catheter-Related Bloodstream Infection Market Industry Survey

Drug Class:

  • Non-antibiotic
  • Anti-infective
  • Antimicrobial

Pathogens:

  • Contaminated Catheter Hub
  • Contaminated Infusate
  • Skin Insertion
  • Hematogenous

Source of Infection:

  • Aureus
  • Aeruginsa
  • CONS
  • Baumanii
  • Coli
  • Pnemoniae
  • Candida sp

Route of Administration:

  • Oral
  • Intravenous

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Comments

Post a Comment

Popular posts from this blog

Biocomposites Market Current and Future Trends, Leading Players, Industry Segments and Regional Forecast By 2032 | Says FMI Analyst

Image
  The Global Biocomposites Market reached more than US$ 25 billion in 2021 and is predicted to increase at an amazing 16% CAGR between 2022 and 2032, reaching over US$ 128 billion by the end of 2032. Biocomposite The increased research and development efforts for composite materials and  biocomposite uses  and benefits such as recyclability, lightweight, and cost-effectiveness are driving this trend. In addition, due to the harmful nature of synthetic materials, recycling challenges, and toxic residues, the  biocomposites market size  will continue to expand throughout the predicted timetable. Request a report sample to gain comprehensive insights at: https://www.futuremarketinsights.com/reports/sample/rep-gb-14293 As per the  biocomposites market report , Germany, the United States, and Japan are among the developed countries working on boosting the usage of ecologically friendly items rather than petroleum-based products.  The European Un...
Read more

Hemostasis Products Market Key Players, Applications, Outlook, SWOT Analysis And Forecasts by 2032

Image
  The global Hemostasis Products Market is expected to be worth US$ 1580 million in 2022. The market is expected to be worth US$ 2638 million between 2022 and 2032, at a CAGR of 5.3%. The rising prevalence of chronic blood disorders can be attributed to the market's expansion. High-level technological advancements, strong economies, and a swarming pool of patients with a variety of blood disorders are the chief factors that will boost the market for hemostasis products in the near future. The leading causes of surgeries are cardiovascular disease and stroke, cancer, and injury. And any surgical procedure can develop severe complications and result in uncontrollable bleeding thus increasing the demand for hemostasis products. Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15386 The rapidly growing medical tourism sector coupled with the high investment made by governments of various countries towards the growth of the healthcare s...
Read more

Solar Inverter Market Size, Top Key Players, Latest Trends, Regional Insights and Global Industry Dynamics By 2032

Image
  The Global Solar Inverter Market Size is expected to expand 5.0% year on year in 2022, reaching a valuation of over US$ 11 Bn . Increased use of renewable energy sources for residential and commercial areas is predicted to drive solar inverter sales at a 6% CAGR over the forecast period. Solar Inverter Increased use of solar panels and renewable energy will fuel industry expansion. High adoption of solar inverters in the residential, commercial, industrial, and utility sectors will continue to drive market sales. Request a sample to gain compressive insights @  https://www.futuremarketinsights.com/reports/sample/rep-gb-6287 Manufacturers have been increasing their product lines with new technological advancements in inverter technologies over the last few years. Because solar energy usage in photovoltaic systems is mostly dependent on the inverter, solar inverters have the potential to reduce global warming and greenhouse gas emissions. "Increasing awareness of en...
Read more